GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Institutional Ownership

TaiMed Biologics (ROCO:4147) Institutional Ownership : 4.97% (As of May. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TaiMed Biologics's institutional ownership is 4.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TaiMed Biologics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TaiMed Biologics's Float Percentage Of Total Shares Outstanding is 0.00%.


TaiMed Biologics Institutional Ownership Historical Data

The historical data trend for TaiMed Biologics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Institutional Ownership Chart

TaiMed Biologics Historical Data

The historical data trend for TaiMed Biologics can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 4.93 5.05 5.01 5.04 4.97 4.97 4.98 4.98 4.97 4.97

TaiMed Biologics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


TaiMed Biologics (ROCO:4147) Business Description

Traded in Other Exchanges
N/A
Address
No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492
TaiMed Biologics Inc is a Taiwan-based biotechnology company. It is engaged in the discovery, development, and delivery of medicines for infectious disease. It capitalizes on its intellectual, extensive expertise, and management resources to develop a health-care product pipeline that benefits patients, rewards investors, and propels to prominence in the biotechnology industry. The company's products pipeline includes TMB-365, VRC07-523LS, and others.

TaiMed Biologics (ROCO:4147) Headlines

No Headlines